Latest News about CRSP
Recent news which mentions CRSP
3 Gene Editing Stocks to Generate Super-Charged Gains
October 18, 2023
Tags
Market News
GNOM
NASDAQ:EDIT,NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:VRTX,NASDAQ:SRPT,NASDAQ:NTLA,NASDAQ:BEAM
From InvestorPlace
From Benzinga
Cautious Optimism For Bluebird Bio's Sickle Cell Therapy: Analyst Sees Financial Challenges
October 17, 2023
From Benzinga
From Benzinga
Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy
October 17, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
From Benzinga
This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street
October 16, 2023
From Motley Fool
From Motley Fool
From Motley Fool
Cathie Wood's Ark Invest Sells $9.8M Worth Of Tesla Shares — Second Day Of Selling EV Giant In A Row
October 11, 2023
From Benzinga
Cathie Wood's Ark Invest Keeps On Cutting Tesla Holdings, Sells More Than $8M Worth Of EV Maker's Shares
October 10, 2023
From Benzinga
From Motley Fool
Cathie Wood Goes Shopping For Stock of Jack Dorsey's Block — Ark Invest Bolsters Portfolio With Archer Aviation, CRISPR Shares
October 09, 2023
From Benzinga
3 No-Brainer Growth Stocks to Buy in October
October 07, 2023
From Motley Fool
From Motley Fool
From Benzinga
From InvestorPlace
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
October 03, 2023
From Motley Fool
2 Top Biotech Stocks to Buy in October
October 03, 2023
From Motley Fool
Better Gene Editing Stock: Editas Medicine vs. CRISPR Therapeutics
October 02, 2023
From Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
October 01, 2023
From Motley Fool
3 Cathie Wood Stocks Set to Explode Higher
October 01, 2023
From InvestorPlace
Futurescape: Betting Big on These 3 Next-Gen Tech Stocks
October 01, 2023
From InvestorPlace
3 No-Brainer Growth Stocks to Buy in October
October 01, 2023
From Motley Fool
Editas Medicine Is Beyond Skepticism, Analyst Has Confidence In Sickle Cell Therapy, Upgrades Stock
September 29, 2023
From Benzinga
Why Editas Medicine Stock Is Soaring Today
September 29, 2023
From Motley Fool
If I Could Only Buy 3 Stocks in 2023, I'd Pick These
September 29, 2023
From Motley Fool
2 Bargain Growth Stocks to Buy Hand Over Fist
September 28, 2023
From Motley Fool
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
September 27, 2023
From InvestorPlace
From Dust to Diamonds: 7 Undervalued Stocks With Sparkling Prospects
September 27, 2023
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.